Abstract
Axial deformities such as camptocormia or Pisa syndrome in people with Parkinson’s disease (PwP) are poorly understood. The scarcity of information may result from the shortage of reliable and responsive evaluation instruments. We evaluated the body height loss (BHL) as a new measure for PwP with axial deformities. 50 PwP with axial deformity defined by an UPDRS item 28 value of at least 2 were included in this mono-center study. We measured body height while lying supine and after 1 min of standing, providing a percentage value of BHL, and compared this measure to other clinical variables. BHL depended on the Hoehn and Yahr clinical stage and correlated with clinical scales for function and mobility, but not with timely measures of the axial disorder such as age at diagnosis or duration of disease. ANOVA showed that only lumbar flexion explained the variability of BHL (F = 21.0, p < 0.0001), but not kyphosis (F = 0.4, p = 0.74) or lateroflexion (F = 0.6, p = 0.6). Re-test reliability of BHL was good with к = 0.76 (p < 0.0001). BHL resulted from the lumbar spine and the hip joint and not from the thoracic spine or lateroflexion. This observation conforms to the concept of upper-type and lower-type camptocormia with only the latter leading to a BHL. The assessment of the BHL is shown to be a well defined, easy to perform, and reliable measure for the clinical evaluation of lower-type camptocormia.
Similar content being viewed by others
References
Abdulhadi HM, Kerrigan DC (1996) Camptocormia: a biomechanical analysis. A case report. Am J Phys Med Rehabil Assoc Acad Physiatr 75:310–313
Abe K, Uchida Y, Notani M (2010) Camptocormia in Parkinson’s disease. Park Dis. https://doi.org/10.4061/2010/267640
Ashour R, Jankovic J (2006) Joint and skeletal deformities in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord 21:1856–1863
Azher SN, Jankovic J (2005) Camptocormia: pathogenesis, classification, and response to therapy. Neurology 65:355–359
Bettany-Saltikov J, Weiss H-R, Chockalingam N, Taranu R, Srinivas S, Hogg J, Whittaker V, Kalyan RV, Arnell T (2015) Surgical versus non-surgical interventions in people with adolescent idiopathic scoliosis. In: The Cochrane Collaboration (Ed.), Cochrane Database Syst. Rev. Wiley, Chichester
Bloch F, Houeto JL, Tezenas du Montcel S, Bonneville F, Etchepare F, Welter ML, Rivaud-Pechoux S, Hahn-Barma V, Maisonobe T, Behar C, Lazennec JY, Kurys E, Arnulf I, Bonnet AM, Agid Y (2006) Parkinson’s disease with camptocormia. J Neurol Neurosurg Psychiatry 77:1223–1228
Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A (2016) Movement Disorders Society Rating Scales Committee, Measurement instruments to assess posture, gait, and balance in Parkinson’s disease: Critique and recommendations. Mov Disord 31:1342–1355
de Sèze M-P, Creuzé A, de Sèze M, Mazaux J-M (2008) An orthosis and physiotherapy programme for camptocormia: a prospective case study. J Rehabil Med 40:761–765
de Sèze MP, Guillaud E, Slugacz L, Cazalets JR (2015) An examination of camptocormia assessment by dynamic quantification of sagittal posture. J Rehabil Med 47:72–79
Djaldetti R, Melamed E (2006) Camptocormia in Parkinson’s disease: new insights. J Neurol Neurosurg Psychiatry 77:1205
Djaldetti R, Mosberg-Galili R, Sroka H, Merims D, Melamed E (1999) Camptocormia (bent spine) in patients with Parkinson’s disease—characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 14:443–447
Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay J-P, Gershanik OS, Bloem BR (2011) Postural deformities in Parkinson’s disease. Lancet Neurol 10:538–549
Fasano A, Geroin C, Berardelli A, Bloem BR, Espay AJ, Hallett M, Lang AE, Tinazzi M (2018) Diagnostic criteria for camptocormia in Parkinson’s disease: a consensus-based proposal. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2018.04.033
Forsyth AL, Paul SS, Allen NE, Sherrington C, Fung VSC, Canning CG (2017) Flexed truncal posture in parkinson disease: measurement reliability and relationship with physical and cognitive impairments, mobility, and balance. J Neurol Phys Ther 41:107–113
Furusawa Y, Mukai Y, Kobayashi Y, Sakamoto T, Murata M (2012) Role of the external oblique muscle in upper camptocormia for patients with Parkinson’s disease. Mov Disord 27:802–803
Gandor F, Basta D, Gruber D, Poewe W, Ebersbach G (2016) Subjective visual vertical in PD patients with lateral trunk flexion. Park Dis 2016:7489105. https://doi.org/10.1155/2016/7489105
Gdynia H-J, Sperfeld A-D, Unrath A, Ludolph AC, Sabolek M, Storch A, Kassubek J (2009) Histopathological analysis of skeletal muscle in patients with Parkinson’s disease and “dropped head’/’bent spine” syndrome. Parkinsonism Relat Disord 15:633–639
Gibb WR, Lees AJ (1988) A comparison of clinical and pathological features of young- and old-onset Parkinson’s disease. Neurology 38:1402–1406
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement disorder society-sponsored revision of the unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Inzelberg R, Hattori N, Nisipeanu P, Abo Mouch S, Blumen SC, Carasso RL, Mizuno Y (2003) Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation. Neurology 60:1393–1394
Lepoutre AC, Devos D, Blanchard-Dauphin A, Pardessus V, Maurage CA, Ferriby D, Hurtevent JF, Cotten A, Destee A, Defebvre L (2006) A specific clinical pattern of camptocormia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:1229–1234
Margraf NG, Wrede A, Rohr A, Schulz-Schaeffer WJ, Raethjen J, Eymess A, Volkmann J, Mehdorn MH, Jansen O, Deuschl G (2010) Camptocormia in idiopathic Parkinson’s disease: a focal myopathy of the paravertebral muscles. Mov Disord 25:542–551
Margraf NG, Granert O, Hampel J, Wrede A, Schulz-Schaeffer WJ, Deuschl G (2017) Clinical definition of camptocormia in Parkinson’s disease. Mov Disord Clin Pract 4:349–357
Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Volkmann J, Berg D, Deuschl G (2018) Consensus for the measurement of the camptocormia angle in the standing patient. Parkinsonism Relat Disord 52:1–5
Nikfekr E, Kerr K, Attfield S, Playford DE (2002) Trunk movement in Parkinson’s disease during rising from seated position. Mov Disord 17:274–282
Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148
Song W, Guo X, Chen K, Huang R, Zhao B, Cao B, Chen Y, Shang HF (2014) Camptocormia in Chinese patients with Parkinson’s disease. J Neurol Sci 337:173–175
Srivanitchapoom P, Hallett M (2016) Camptocormia in Parkinson’s disease: definition, epidemiology, pathogenesis and treatment modalities. J Neurol Neurosurg Psychiatry 87:75–85
St George RJ, Gurfinkel VS, Kraakevik J, Nutt JG, Horak FB (2018) Case studies in neuroscience: a dissociation of balance and posture demonstrated by camptocormia. J Neurophysiol 119:33–38
Tramonti C, Di Martino S, Unti E, Frosini D, Bonuccelli U, Rossi B, Ceravolo R, Chisari C (2017) Gait dynamics in pisa syndrome and camptocormia: the role of stride length and hip kinematics. Gait Posture 57:130–135
Wrede A, Margraf NG, Goebel HH, Deuschl G (2012) W.J. Schulz-Schaeffer, Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson’s disease. Acta Neuropathol (Berl) 123:419–432
Wright WG, Gurfinkel VS, King LA, Nutt JG, Cordo PJ, Horak FB (2010) Axial kinesthesia is impaired in Parkinson’s disease: effects of levodopa. Exp Neurol 225:202–209
Acknowledgements
We want to thank the Deutsche Stiftung Neurologie and the Deutsche Parkinson Vereinigung for generously supporting this research. We want to thank the involved patients for their collaboration.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states there is no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fietzek, U.M., Schroeteler, F.E., Hahn, L. et al. Body height loss characterizes camptocormia in Parkinson’s disease. J Neural Transm 125, 1473–1480 (2018). https://doi.org/10.1007/s00702-018-1912-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-018-1912-2